STRIVERDI RESPIMAT (olodaterol hydrochloride) Boehringer ingelheim Patent: 7,056,916 Expiration: Dec 7, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Pa…
Drug Patent Expirations for the Week of December 3, 2023 Read Post »
Annual Drug Patent Expirations for ELCYS Elcys is a drug marketed by Exela Pharma and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent for Exela Pharma drug ELCYS appeared first on DrugPatentWat…
Annual Drug Patent Expirations for ZEGALOGUE Zegalogue is a drug marketed by Zealand Pharma and is included in one NDA. It is available from two suppliers. There is one patent…
The post New patent for Zealand Pharma drug ZEGALOGUE appeared first on Dru…
Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Boehringer Ingelheim d…
New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT Read Post »
Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Boehringer Ingelhe…
New patent expiration for Boehringer Ingelheim drug STRIVERDI RESPIMAT Read Post »
This chart shows the pharmaceutical companies with the most cream dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most cream dosed drugs…
The post Which pharmaceutical companies have the most cream do…
Which pharmaceutical companies have the most cream dosed drugs? Read Post »
Annual Drug Patent Expirations for RADICAVA+ORS Radicava Ors is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one supplier. There are three…
The post New patent for Mitsubishi Tanabe drug RADICAVA ORS appeared fi…
New patent for Mitsubishi Tanabe drug RADICAVA ORS Read Post »
This chart shows the pharmaceutical companies with the most implant dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most implant dosed drugs…
The post Which pharmaceutical companies have the most impl…
Which pharmaceutical companies have the most implant dosed drugs? Read Post »
Annual Drug Patent Expirations for ZAVZPRET Zavzpret is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent expiration for Pfizer drug ZAVZPRET appeared first…
Annual Drug Patent Expirations for LUMRYZ Lumryz is a drug marketed by Avadel Cns and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent for Avadel Cns drug LUMRYZ appeared first on DrugPatentWatch…
Get new actionable insights and updates from BiotechBlog
